About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
Evaluation of Clonal Hematopoiesis in Patients With Solid Tumors: Case Discussion
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Eric Padron
By
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
FEATURING
Eric Padron
137 views
February 14, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Videos
38:56
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate on the Use of MRD to Guide Transplant D…
Feat.
H. Fernandez,
N. Bejanyan
31:09
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Updates on BCMA CAR T-Cell for MM: Real World Experience and Fu…
Feat.
M. Alsina
26:02
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Novel Immune-Based Therapy for R/R MM: Interactive Case Discuss…
Feat.
J. Brayer
16:00
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: How Much Is Too Much in NDMM - Triplet…
Feat.
R. Baz
18:44
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet …
Feat.
K. Shain
20:54
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Updates on COVID-19 in Cancer Patients: Outcomes and Prevention
Feat.
A. Giuliano
19:36
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Managing Hematologic Toxicities From Immunotherapeutic Agents
Feat.
M. Jaglal
23:05
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Evaluation of Clonal Hematopoiesis in Patients With Solid Tumors: Ca…
Feat.
E. Padron
22:37
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 Moffitt Cancer Center Updates on the Role of CAR T-Cells in Lym…
Feat.
F. Locke
26:22
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art: Best Frontline Therapy for CLL
Feat.
J. Pinilla-Ibarz
25:53
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center's Updates on Treatment of R/R DLBCL: Inte…
Feat.
S. Gaballa
34:29
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Moffitt Cancer Center Debate: Should NGS Be Reported in All Newly Di…
Feat.
B. Shah,
H. Saeed
27:27
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art Frontline Management of the HR-MDS
Feat.
R. Komrokji
22:48
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Using Molecular Monitoring to Guide Therapy in AML: Interactive Case…
Feat.
K. Sweet
